Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trizivir Treatment Optimisation in HIV-1
NCT00449436Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by GSK. Started Jan 2005; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00449436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449436.